# A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.

> **NCT00549211** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 42 (estimated)

## Conditions studied

- Obstetric Labour, Premature
- Premature Ejaculation

## Interventions

- **DRUG:** GSK557296

## Key facts

- **NCT ID:** NCT00549211
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2012-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00549211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00549211, "A First Time in Human Study in Healthy Male Volunteers for Compound GSK557296.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00549211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*